Pubblicazioni Scientifiche

Ricerca su tutti i campi

Ricerca avanzata

Tipo pubbl.	Pubblicazione
Conference Abstract	Ramanathan R K, Von Hoff D D, Moore M, Teixeira L, Siena S, Tabernero J, Goldstein D, Wei X, Lu B Positron emission tomography (PET) response from a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients (pts) with metastatic adenocarcinoma of the pancreas Eur J Cancer 2013;49( ):S611- .
Research Support; Multicenter Study	Ramirez J, Ruiz-Esquide V, Pomes I, Celis R, Pomes J, Cabrera S, Hernandez M V, Epis O M, Pablos J L, Sanmarti R, Canete J D Higher disease activity and serum levels of angiogenic factors in patients with rheumatoid arthritis in clinical remission with synovitis on ultrasound Arthritis Rheum 2013;65( ):S1231- .
Conference Abstract	Rampoldi A, De Gasperi A, Solcia M, Vercelli R, Migliorisi C, Airoldi A, Barbosa F, Di Marco D, Cornalba G Transjugular intrahepatic portosystemic shunt (TIPS) for treating symptomatic Budd-Chiari syndrome: Patency assessment, overall survival, and long-term results Cardiovasc Intervent Radiol 2013;36( ):S244- .
Conference Abstract	Rattotti S, Arcaini L, Ferretti V V, Rossi A, Fogazzi S, Greco A, Baldini L, Balzarotti M, Pioltelli P, Bonfichi M, Varettoni M, Gotti M, Farina L, Ferreri A J M, Laszlo D, Morra E Non-hodgkin's lymphomas associated with positive hepatitis-c virus infection: A prospective multicentric observational study on behalf of the rete ematologica lombarda/hematology network of lombardia region Blood 2013;122(21): - .
Conference Abstract	Rebutti I, Milanesi G, Sesana F M, Panzavolta G, Stella A, Borghini R, Settimi L, Davanzo F, Celentano A Treatment improvement for drug abuse: A PCC proposal Clin Toxicol 2013;51(7):696- .
Retrospective Studies	Ricci F, Tedeschi A, Vismara E, Colombo C, Veronese S, Nichelatti M, Cairoli R, Morra E, Montillo M Should a Positive Direct Antiglobulin Test Be Considered a Prognostic Predictor in Chronic Lymphocytic Leukemia? Clin Lymphoma Myeloma Leuk 2013; 13 (4): 441-446.
Conference Abstract	Riccobono S, Ribecca D, Cesana F, Bartesagh M, Mean P, Santacesaria S, Colombo G, Sormani P, Nava S, Stucchi M, Pozzi M, Fallanca A, Colombo C, Giannattasio C Usefulness of 6 minutes walking test in the assessment of short term functional improvement induced by cardiac rehabilitation High Blood Press Cardiovasc Prev 2013;20(2):104- .
Letter; Journal Article	Ricotta R, Sartore-Bianchi A, Verrioli A, Vanzulli A, Siena S Regorafenib for metastatic colorectal cancer Lancet 2013;381(9877):1537- .
Journal Article	Ricotta R, Vanzulli A, Moroni M, Colnago B, Oriani M, Nichelatti M, Sarnataro C, Venturini F, Di Bella S, Maiolani M, Giganti M O, Sartore-Bianchi A, Siena S Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab Clin Colorectal Cancer 2013;12(1):45-53. Pubblicazione Elettronica: 2012
Journal Article	Ricotta R, Vanzulli A, Moroni M, Colnago B, Oriani M, Nichelatti M, Sarnataro C, Venturini F, Di Bella S, Maiolani M, Giganti M O, Sartore-Bianchi A, Siena S Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab Clin Colorectal Cancer 2013;12(1):45-53.
Conference Abstract	Rimoldi O, Pedrotti P, Milazzo A, Quattrocchi G, Roghi A Myocardial tissue characterization using magnetic resonance T1 mapping in normal phenotypeand hypertrophic cardiomyopathy Eur Heart J 2013;34( ):540- .
Journal Article	Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, Zoppi N, Vascellaro A, Wischmeijer A, Manfredini E, Garavelli L, Calzavara-Pinton P, Colombi M Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: Identification of 18 COL5A1 and 2 COL5A2 novel mutations Orphanet J Rare Dis 2013;8(1): - .
Conference Abstract	Riva N, Scarlato M, Scarlino S, Del Bo R, Comi G P, Corbo M, Penco S, Ferrari M, Foglio A, Grimaldi L M, Comi G, Nobile-Orazio E, Marrosu M G, Del Carro U, Gerevini S, Fazio R, Quattrini A, Bolino A, Previtali S C Clinical and molecular characterization of a cohort of patients with distal motor neuropathy J Peripher Nerv Syst 2013;18( ):S28-S29.
Conference Abstract	Rockstroh J K, Nelson M, Soriano V, Arasteh K, Guardiola J M, Bhagani S, Mallolas J, Tural C, Puoti M, Ingiliz P, Battegay M, Jain M K, Nunez M, Marks K M, Kort J J, Stern J O, Vinisko R, Manero M, Dieterich D T STARTVerso 4 phase III trial of faldaprevir plus peg interferon alfa-2a and ribavirin (PR) in patients with HIV and HCV genotype 1 coinfection: End of treatment response Hepatology 2013;58(4):741A-742A.
Conference Abstract	Rockstroh J K, Nelson M, Soriano V, Arasteh K, Guardiola J, Bhagani S, Mallolas J, Tural C, Puoti M, Ingiliz P, Battegay M, Jain M K, Marks K, Kort J, Stern J, Vinisko R, Manero M, Dieterich D STARTVerso 4 Phase III trial of faldaprevir oncedaily plus peg interferon alfa-2a and ribavirin (PR) in patients with HIV and HCV genotype 1 coinfection: End of treatment response (ETR) Antiviral Ther 2013;18( ):A12- .
Review	Roghi A Iron and cardiotoxicity: From thalassemia to reperfusion injury G Ital Cardiol 2013;14(6):438-444.
Journal Article	Romano D, Sedda A, Dell'Aquila R, Dalla Costa D, Beretta G, Maravita A, Bottini G Controlling the alien hand through the mirror box. A single case study of Alien Hand Syndrome Neurocase 2014;20(3):307 -316. Pubblicazione Elettronica: 2013
Evaluation Studies	Ross J, Sharma S, Winston J, Nunez M, Bottini G, Franceschi M, Scarpini E, Frigerio E, Fiorentini F, Fernandez M, Sivilia S, Giardino L, Calza L, Norris D, Cicirello H, Casula D, Imbimbo B P CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: A 12-week, double-blind, placebo-controlled study Curr Alzheimer Res 2013;10(7):742-743.
Conference Abstract	Rossi G, Marcheselli L, Bottelli C, Tucci A, Dondi A, Luminari S, Arcaini L, Merli M, Pulsoni A, Boccomini C, Puccini B, Micheletti M, Martinelli G, Rossi A, Zilioli V R, Bozzoli V, Balzarotti M, Bolis S, Cabras M G, Federico M The use of rituximab at first line does not impair the efficacy of second-line therapy in patients with follicular lymphoma. Results of the refoll study by the fondazione Italiana linfomi Hematol Oncol 2013;31( ):163- .
Journal Article	Rossini R, Baroni M, Musumeci G, Gavazzi A Oral antiplatelet therapy after drug-eluting stent implantation: Adherence and side-effects J Cardiovasc Med 2013;14(2):81-90.

Risultati da 3641 a 3660 di 6391 totali

Precedente -

- Successiva

AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA | Piazza Ospedale Maggiore 3 | 20162 Milano | t. +39 02 6444.1 - f. +39 02 6420901 | CF e Partita IVA: 11390840152